Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 4 1Phase 2 1

Status

Recruiting 5Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Colorectal Neoplasms 48Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Non-Small-Cell Lung 15Neoplasms 11Head and Neck Neoplasms 9Neoplasm Metastasis 8Lung Neoplasms 8Pancreatic Neoplasms 7Colonic Neoplasms 7Carcinoma, Squamous Cell 7Solid Tumors 5Rectal Neoplasms 4Ovarian Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Colorectal Cancer Metastatic 3Carcinoma 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Recurrence 2Oropharyngeal Neoplasms 2Melanoma 2Locally Recurrent Rectal Cancer 2Carcinoma, Pancreatic Ductal 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1

Interventions

Cetuximab 5pembrolizumab 3Injections 3Bevacizumab 2taxane 1ribociclib 1pegylated granulocyte colony-stimulating factor 1olaparib 1fludarabine phosphate 1fludarabine 1encorafenib 1dapagliflozin 1cemiplimab 1binimetinib 1anlotinib 1amivantamab 1adagrasib 1Pemetrexed 1Oxaliplatin 1Leucovorin 1Irinotecan 1Immunotherapy, Adoptive 1IFL protocol 1Folfox protocol 1Fluorouracil 1Filgrastim 1Docetaxel 1Cyclophosphamide 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Solid Tumors × Cetuximab × Clear all
NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Mirati Therapeutics Inc.

Phase 2 Recruiting
170 enrolled
Other solid neoplasm

Solid Tumors

NCT06227377 2026-04-27

QTX3034 in Patients With KRAS G12D Mutation

Quanta Therapeutics

Phase 1 Recruiting
250 enrolled
Other solid neoplasm

Solid Tumors

NCT05203172 2026-04-07

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Pfizer

Phase 4 Recruiting
46 enrolled
Other solid neoplasm

Solid Tumors

NCT07030959 2026-02-25

Study of AUBE00 in Patients With Solid Tumors

Chugai Pharmaceutical

Phase 1 Recruiting
130 enrolled
Other solid neoplasm

Solid Tumors

NCT05836324 2025-12-18

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Incyte Corporation

Phase 1 Recruiting
408 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡